NetWorth
LeaderPortfolio
Hongbin
Cai Hongbin
Rank #3196
CHINA•Healthcare•Pharmaceuticals

Cai Hongbin

Net Worth
$1.094B
0% (24h)
Cai Hongbin is a Chinese businessman and academic. As of March 2026, he is ranked #3185 on Forbes' Billionaires list, with a net worth of $1.1 billion, primarily derived from his stake in Jiangsu Hengrui Medicine, one of China's largest pharmaceutical companies. He is the Dean of the HKU Business School and Chair of Economics. Cai is also a member of the National People's Congress and has held positions as an independent director on several boards, including China Petroleum & Chemical Corporation. His career spans academia and business, with a focus on economic research and finance.

How to read Cai Hongbin's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Cai Hongbin, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $1.094B alongside global rank #3196, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (CHINA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life and Education

Cai Hongbin's career began with a strong foundation in academia. He earned a B.A. in Mathematics from Wuhan University in 1988. This was followed by an M.A. in Economics from Peking University in 1991. He furthered his education in the United States, obtaining a Ph.D. in Economics from Stanford University in 1997.

Academic Career and Rise to Success

From 1997 to 2005, Cai taught at the University of California, Los Angeles. He then returned to China, becoming Dean of the Guanghua School of Management at Peking University from December 2010 to January 2017. In June 2017, Cai joined the HKU Business School, becoming Dean in July 2017. His research focuses on economics and finance, including game theory, the Chinese economy, industrial organization, and corporate finance. He has published numerous academic papers in top international journals and was elected as a Fellow of the Econometric Society.

Business Ventures and Key Business Strategies

Cai's wealth comes from his stake in Jiangsu Hengrui Medicine, a major pharmaceutical company in China. He has served as an independent director on the boards of several corporations, including CCB International (Holdings) Limited and China Petroleum & Chemical Corporation.

Philanthropy

Information regarding Cai Hongbin's specific philanthropic activities and the amounts donated is not readily available through search results. More research may be needed to find the information.

Career Timeline

2017-Present

Dean

Dean of the HKU Business School.

2010-2017

Dean

Served as Dean of Guanghua School of Management, Peking University.

1997-2005

Professor

Taught at the University of California, Los Angeles.

1997

Graduated

Obtained a Ph.D. in Economics from Stanford University.

1991

Graduated

Received an M.A. in Economics from Peking University.

1988

Graduated

Received a B.A. in Mathematics from Wuhan University.

Philanthropic Impact

Unknown$XB

Unknown

Unknown

Key Business Ventures & Holdings

CompanyStakeValue
Jiangsu Hengrui Medicine——

Net Worth History

In-Depth Analysis

Early Life and Education

Cai Hongbin's career began with a strong foundation in academia. He earned a B.A. in Mathematics from Wuhan University in 1988. This was followed by an M.A. in Economics from Peking University in 1991. He furthered his education in the United States, obtaining a Ph.D. in Economics from Stanford University in 1997.

Academic Career and Rise to Success

From 1997 to 2005, Cai taught at the University of California, Los Angeles. He then returned to China, becoming Dean of the Guanghua School of Management at Peking University from December 2010 to January 2017. In June 2017, Cai joined the HKU Business School, becoming Dean in July 2017. His research focuses on economics and finance, including game theory, the Chinese economy, industrial organization, and corporate finance. He has published numerous academic papers in top international journals and was elected as a Fellow of the Econometric Society.

Business Ventures and Key Business Strategies

Cai's wealth comes from his stake in Jiangsu Hengrui Medicine, a major pharmaceutical company in China. He has served as an independent director on the boards of several corporations, including CCB International (Holdings) Limited and China Petroleum & Chemical Corporation.

Philanthropy

Information regarding Cai Hongbin's specific philanthropic activities and the amounts donated is not readily available through search results. More research may be needed to find the information.

Data Sources & Methodology

Figures for Cai Hongbin are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom